Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

In vitro elimination of EGFR-overexpressing cancer cells by CD32A chimeric receptor T cells in combination with cetuximab or panitumumab.

Caratelli S, Arriga R, Sconocchia T, Ottaviani A, Lanzilli G, Pastore D, Cenciarelli C, Venditti A, Del Principe MI, Lauro D, Landoni E, Du H, Savoldo B, Ferrone S, Dotti G, Sconocchia G.

Int J Cancer. 2019 Sep 3. doi: 10.1002/ijc.32663. [Epub ahead of print]

PMID:
31479522
2.

Pedicularis L. Genus: Systematics, Botany, Phytochemistry, Chemotaxonomy, Ethnopharmacology, and Other.

Frezza C, Venditti A, Toniolo C, Vita D, Serafini I, Ciccòla A, Franceschin M, Ventrone A, Tomassini L, Foddai S, Guiso M, Nicoletti M, Bianco A, Serafini M.

Plants (Basel). 2019 Aug 27;8(9). pii: E306. doi: 10.3390/plants8090306. Review.

3.

An evaluation of enasidenib for the treatment of acute myeloid leukemia.

Del Principe MI, Paterno G, Palmieri R, Maurillo L, Buccisano F, Venditti A.

Expert Opin Pharmacother. 2019 Aug 27:1-8. doi: 10.1080/14656566.2019.1654456. [Epub ahead of print]

PMID:
31454277
4.

MRD in AML: The Role of New Techniques.

Voso MT, Ottone T, Lavorgna S, Venditti A, Maurillo L, Lo-Coco F, Buccisano F.

Front Oncol. 2019 Jul 23;9:655. doi: 10.3389/fonc.2019.00655. eCollection 2019. Review.

5.

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.

Venditti A, Piciocchi A, Candoni A, Melillo L, Calafiore V, Cairoli R, de Fabritiis P, Storti G, Salutari P, Lanza F, Martinelli G, Luppi M, Mazza P, Martelli MP, Cuneo A, Albano F, Fabbiano F, Tafuri A, Chierichini A, Tieghi A, Fracchiolla NS, Capelli D, Foà R, Alati C, La Sala E, Fazi P, Vignetti M, Maurillo L, Buccisano F, Del Principe MI, Irno-Consalvo M, Ottone T, Lavorgna S, Voso MT, Lo-Coco F, Arcese W, Amadori S.

Blood. 2019 Sep 19;134(12):935-945. doi: 10.1182/blood.2018886960. Epub 2019 Aug 8.

PMID:
31395600
6.

Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse.

Iaccarino L, Ottone T, Alfonso V, Cicconi L, Divona M, Lavorgna S, Travaglini S, Ferrantini A, Falconi G, Baer C, Usai M, Forghieri F, Venditti A, Del Principe MI, Arcese W, Voso MT, Haferlach T, Lo-Coco F.

Am J Hematol. 2019 Oct;94(10):1091-1097. doi: 10.1002/ajh.25573. Epub 2019 Jul 23.

PMID:
31292998
7.

Composition and biological activities of the essential oil from a Sicilian accession of Prangos ferulacea (L.) Lindl.

Bruno M, Ilardi V, Lupidi G, Quassinti L, Bramucci M, Fiorini D, Venditti A, Maggi F.

Nat Prod Res. 2019 Apr 8:1-11. doi: 10.1080/14786419.2019.1598996. [Epub ahead of print]

PMID:
30957559
8.

The emerging role of measurable residual disease detection in AML in morphologic remission.

Buccisano F, Maurillo L, Schuurhuis GJ, Del Principe MI, Di Veroli A, Gurnari C, Venditti A.

Semin Hematol. 2019 Apr;56(2):125-130. doi: 10.1053/j.seminhematol.2018.09.001. Epub 2018 Sep 19. Review.

PMID:
30926088
9.

The Nonvolatile and Volatile Metabolites of Prangos ferulacea and Their Biological Properties.

Bruno M, Ilardi V, Lupidi G, Quassinti L, Bramucci M, Fiorini D, Venditti A, Maggi F.

Planta Med. 2019 Aug;85(11-12):815-824. doi: 10.1055/a-0873-8622. Epub 2019 Mar 20. Review.

PMID:
30895566
10.

The Therapeutic Potential of Apigenin.

Salehi B, Venditti A, Sharifi-Rad M, Kręgiel D, Sharifi-Rad J, Durazzo A, Lucarini M, Santini A, Souto EB, Novellino E, Antolak H, Azzini E, Setzer WN, Martins N.

Int J Mol Sci. 2019 Mar 15;20(6). pii: E1305. doi: 10.3390/ijms20061305. Review.

11.

Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management.

Girmenia C, Busca A, Candoni A, Cesaro S, Luppi M, Nosari AM, Pagano L, Rossi G, Venditti A, Aversa F.

Med Mycol. 2019 Apr 1;57(Supplement_2):S127-S137. doi: 10.1093/mmy/myy091.

PMID:
30816979
12.

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia.

Alfonso V, Iaccarino L, Ottone T, Cicconi L, Lavorgna S, Divona M, Cairoli R, Cristiano A, Ciardi C, Travaglini S, Falconi G, Hasan SK, Venditti A, Arcese W, Voso MT, Lo-Coco F.

Leukemia. 2019 Jun;33(6):1527-1530. doi: 10.1038/s41375-018-0298-3. Epub 2019 Jan 16. No abstract available.

PMID:
30651632
13.

'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.

Del Principe MI, Dragonetti G, Verga L, Candoni A, Marchesi F, Cattaneo C, Delia M, Potenza L, Farina F, Ballanti S, Decembrino N, Castagnola C, Nadali G, Fanci R, Orciulo E, Veggia B, Offidani M, Melillo L, Manetta S, Tumbarello M, Venditti A, Busca A, Aversa F, Pagano L; Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) Group .

J Antimicrob Chemother. 2019 Apr 1;74(4):1062-1068. doi: 10.1093/jac/dky550.

PMID:
30649413
14.

Secondary metabolites of Tilia tomentosa Moench inflorescences collected in Central Italy: chemotaxonomy relevance and phytochemical rationale of traditional use.

Frezza C, De Vita D, Spinaci G, Sarandrea M, Venditti A, Bianco A.

Nat Prod Res. 2019 Jan 12:1-8. doi: 10.1080/14786419.2018.1550487. [Epub ahead of print]

PMID:
30638062
15.

What is and what should never be: artifacts, improbable phytochemicals, contaminants and natural products.

Venditti A.

Nat Prod Res. 2018 Dec 22:1-18. doi: 10.1080/14786419.2018.1543674. [Epub ahead of print]

PMID:
30580596
16.

A new byciclic monoterpene glucoside and a new biflavone from the male reproduction organs of Wollemia nobilis.

Venditti A, Frezza C, Rossi G, Serafini I, Ciccòla A, Sciubba F, Foddai S, Tomassini L, Bianco A, Serafini M.

Fitoterapia. 2019 Mar;133:62-69. doi: 10.1016/j.fitote.2018.12.012. Epub 2018 Dec 17.

PMID:
30572087
17.

Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype.

Baron F, Stevens-Kroef M, Kicinski M, Meloni G, Muus P, Marie JP, Halkes CJM, Thomas X, Vrhovac R, Albano F, Lefrère F Sr, Sica S, Mancini M, Venditti A, Hagemeijer A, Jansen JH, Amadori S, de Witte T, Willemze R, Suciu S.

Haematologica. 2019 Jun;104(6):1168-1175. doi: 10.3324/haematol.2018.204826. Epub 2018 Dec 6.

18.

Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome.

Del Principe MI, Buccisano F, Soddu S, Maurillo L, Cefalo M, Piciocchi A, Consalvo MI, Paterno G, Sarlo C, De Bellis E, Zizzari A, De Angelis G, Fraboni D, Divona M, Voso MT, Sconocchia G, Del Poeta G, Lo-Coco F, Arcese W, Amadori S, Venditti A.

Semin Hematol. 2018 Oct;55(4):209-214. doi: 10.1053/j.seminhematol.2018.02.006. Epub 2018 Feb 21. Review.

PMID:
30502849
19.

A syn-ent-labdadiene derivative with a rare spiro-β-lactone function from the male cones of Wollemia nobilis.

Venditti A, Frezza C, Vincenti F, Brodella A, Sciubba F, Montesano C, Franceschin M, Sergi M, Foddai S, Di Cocco ME, Curini R, Delfini M, Bianco A, Serafini M.

Phytochemistry. 2019 Feb;158:91-95. doi: 10.1016/j.phytochem.2018.11.012. Epub 2018 Nov 24.

PMID:
30481664
20.

Novel Agents for Acute Myeloid Leukemia.

Luppi M, Fabbiano F, Visani G, Martinelli G, Venditti A.

Cancers (Basel). 2018 Nov 9;10(11). pii: E429. doi: 10.3390/cancers10110429. Review.

21.

Sulfur-containing secondary metabolites as neuroprotective agents.

Venditti A, Bianco A.

Curr Med Chem. 2018 Sep 11. doi: 10.2174/0929867325666180912105036. [Epub ahead of print]

PMID:
30207214
22.

Artifacts in natural products studies. An old and underestimated re-emerging problem.

Venditti A.

Nat Prod Res. 2018 Apr;32(7):i-ii. doi: 10.1080/14786419.2018.1443421. No abstract available.

PMID:
30176745
23.

Phytochemical profile of Euphorbia peplus L. collected in Central Italy and NMR semi-quantitative analysis of the diterpenoid fraction.

Frezza C, Venditti A, Sciubba F, Tomai P, Antonetti M, Franceschin M, Di Cocco ME, Gentili A, Delfini M, Serafini M, Bianco A.

J Pharm Biomed Anal. 2018 Oct 25;160:152-159. doi: 10.1016/j.jpba.2018.07.059. Epub 2018 Jul 31.

PMID:
30086508
24.

Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia.

Buccisano F, Dillon R, Freeman SD, Venditti A.

Cancers (Basel). 2018 Jun 26;10(7). pii: E215. doi: 10.3390/cancers10070215. Review.

25.

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.

Maurillo L, Buccisano F, Spagnoli A, Voso MT, Fianchi L, Papayannidis C, Gaidano GL, Breccia M, Musto P, De Bellis E, Del Principe MI, Lunghi M, Lessi F, Martinelli G, Venditti A.

Ann Hematol. 2018 Oct;97(10):1767-1774. doi: 10.1007/s00277-018-3374-x. Epub 2018 Jun 10.

PMID:
29947973
26.

Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.

Baron F, Stevens-Kroef M, Kicinski M, Meloni G, Muus P, Marie JP, Halkes CJM, Thomas X, Vrhovac R, Specchia G, Lefrere F Sr, Sica S, Mancini M, Venditti A, Hagemeijer A, Becker H, Jansen JH, Amadori S, de Witte T, Willemze R, Suciu S.

Ann Hematol. 2018 Oct;97(10):1785-1795. doi: 10.1007/s00277-018-3396-4. Epub 2018 Jun 20.

27.

Bioactive Constituents of Juniperus turbinata Guss. from La Maddalena Archipelago.

Venditti A, Maggi F, Quassinti L, Bramucci M, Lupidi G, Ornano L, Ballero M, Sanna C, Bruno M, Rosselli S, Bianco A.

Chem Biodivers. 2018 Aug;15(8):e1800148. doi: 10.1002/cbdv.201800148. Epub 2018 Jun 28.

PMID:
29790302
28.

Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia.

Buccisano F, Maurillo L, Del Principe MI, Di Veroli A, De Bellis E, Biagi A, Zizzari A, Rossi V, Rapisarda V, Amadori S, Voso MT, Lo-Coco F, Arcese W, Venditti A.

Expert Rev Hematol. 2018 Apr;11(4):307-313. doi: 10.1080/17474086.2018.1447378. Epub 2018 Mar 7. Review.

PMID:
29495904
29.

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

Ottone T, Alfonso V, Iaccarino L, Hasan SK, Mancini M, Divona M, Lavorgna S, Cicconi L, Panetta P, Maurillo L, Del Principe MI, Irno Consalvo M, Franceschini L, Angelini DF, Battistini L, Guerrera G, De Bardi M, Fabiani E, Falconi G, Arcese W, Amadori S, Buccisano F, Venditti A, Voso MT, Lo-Coco F.

Am J Hematol. 2018 May;93(5):E120-E123. doi: 10.1002/ajh.25061. Epub 2018 Feb 24. No abstract available.

30.

Oxidative Stress in Metabolic Disorders and Drug-Induced Injury: The Potential Role of Nrf2 and PPARs Activators.

Mahmoud AM, Alexander MY, Tutar Y, Wilkinson FL, Venditti A.

Oxid Med Cell Longev. 2017;2017:2508909. doi: 10.1155/2017/2508909. Epub 2017 Nov 19. No abstract available.

31.

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

Schuurhuis GJ, Heuser M, Freeman S, Béné MC, Buccisano F, Cloos J, Grimwade D, Haferlach T, Hills RK, Hourigan CS, Jorgensen JL, Kern W, Lacombe F, Maurillo L, Preudhomme C, van der Reijden BA, Thiede C, Venditti A, Vyas P, Wood BL, Walter RB, Döhner K, Roboz GJ, Ossenkoppele GJ.

Blood. 2018 Mar 22;131(12):1275-1291. doi: 10.1182/blood-2017-09-801498. Epub 2018 Jan 12. Review.

32.

Iridoids of Chemotaxonomy Relevance, a New Antirrhinoside Ester and Other Constituents from Kickxia spuria subsp. integrifolia (Brot.) R.Fern.

Venditti A, Frezza C, Serafini I, Ciccòla A, Sciubba F, Serafini M, Bianco A.

Chem Biodivers. 2018 Feb;15(2). doi: 10.1002/cbdv.201700473. Epub 2018 Jan 22.

PMID:
29239523
33.

Iridoid glycosides and polyphenolic compounds from Teucrium chamaedrys L.

Frezza C, Venditti A, Matrone G, Serafini I, Foddai S, Bianco A, Serafini M.

Nat Prod Res. 2018 Jul;32(13):1583-1589. doi: 10.1080/14786419.2017.1392948. Epub 2017 Oct 23.

PMID:
29058476
34.

Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?

Girmenia C, Annino L, Bertaina A, Mariotti B, Caselli D, Fanci R, Barberi W, Marchesi F, Carotti A, Ferrari A, Cerchiara E, Cupelli L, Arcioni F, Ribersani M, Proia A, Cartoni C, Girardi K, Venditti A, Cassetta MI, Fallani S, Novelli A.

Med Mycol. 2018 Apr 1;56(3):263-278. doi: 10.1093/mmy/myx053.

PMID:
28992093
35.

Thrombosis in adult patients with acute leukemia.

Del Principe MI, Del Principe D, Venditti A.

Curr Opin Oncol. 2017 Nov;29(6):448-454. doi: 10.1097/CCO.0000000000000402. Review.

PMID:
28841588
36.

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

Falantes J, Pleyer L, Thépot S, Almeida AM, Maurillo L, Martínez-Robles V, Stauder R, Itzykson R, Pinto R, Venditti A, Bargay J, Burgstaller S, Martínez MP, Seegers V, Cortesão E, Foncillas MÁ, Gardin C, Montesinos P, Musto P, Fenaux P, Greil R, Sanz MA, Ramos F; European ALMA + Investigators.

Leuk Lymphoma. 2018 May;59(5):1113-1120. doi: 10.1080/10428194.2017.1365854. Epub 2017 Aug 24.

PMID:
28838276
37.

Treatment of Low-Blast Count AML using Hypomethylating Agents.

De Bellis E, Fianchi L, Buccisano F, Criscuolo M, Maurillo L, Cicconi L, Brescini M, Del Principe MI, Di Veroli A, Venditti A, Amadori S, Arcese W, Lo-Coco F, Voso MT.

Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017045. doi: 10.4084/MJHID.2017.045. eCollection 2017. Review.

38.

Reassessment of the polar fraction of Stachys alopecuros (L.) Benth. subsp. divulsa (Ten.) Grande (Lamiaceae) from the Monti Sibillini National Park: A potential source of bioactive compounds.

Venditti A, Frezza C, Lorenzetti LM, Maggi F, Serafini M, Bianco A.

J Intercult Ethnopharmacol. 2017 Apr 12;6(2):144-153. doi: 10.5455/jice.20170327073801. eCollection 2017 Apr-Jun.

39.

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance.

Caratelli S, Sconocchia T, Arriga R, Coppola A, Lanzilli G, Lauro D, Venditti A, Del Principe MI, Buccisano F, Maurillo L, Ferrone S, Sconocchia G.

Front Immunol. 2017 Apr 27;8:457. doi: 10.3389/fimmu.2017.00457. eCollection 2017. Review.

40.

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.

Musto P, Maurillo L, Simeon V, Poloni A, Finelli C, Balleari E, Ricco A, Rivellini F, Cortelezzi A, Tarantini G, Villani O, Mansueto G, Milella MR, Scapicchio D, Marziano G, Breccia M, Niscola P, Sanna A, Clissa C, Voso MT, Fenu S, Venditti A, Santini V, Angelucci E, Levis A.

Br J Haematol. 2017 Jun;177(5):741-750. doi: 10.1111/bjh.14621. Epub 2017 Apr 17.

PMID:
28419408
41.

Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.

Aversa F, Busca A, Candoni A, Cesaro S, Girmenia C, Luppi M, Nosari AM, Pagano L, Romani L, Rossi G, Venditti A, Novelli A.

J Chemother. 2017 Jun;29(3):131-143. doi: 10.1080/1120009X.2017.1306183. Epub 2017 Mar 24. Review.

PMID:
28335692
42.

Terpenoids and More Polar Compounds from the Male Cones of Wollemia nobilis.

Venditti A, Frezza C, Sciubba F, Foddai S, Serafini M, Bianco A.

Chem Biodivers. 2017 Mar;14(3). doi: 10.1002/cbdv.201600332. Epub 2017 Mar 11.

PMID:
28296157
43.

New Coumarinyl Ethers in Daphne oleoides Schreb. Collected from Sardinia Island.

Venditti A, Sanna C, Lorenzetti LM, Ballero M, Bianco A.

Chem Biodivers. 2017 Jun;14(6). doi: 10.1002/cbdv.201700072. Epub 2017 May 23.

PMID:
28281331
44.

Phytochemical analysis of the ethanolic extract of Agathis robusta (C. Moore ex F. Muell.) F.M. Bailey.

Venditti A, Frezza C, Campanelli C, Foddai S, Bianco A, Serafini M.

Nat Prod Res. 2017 Jul;31(14):1604-1611. doi: 10.1080/14786419.2017.1288625. Epub 2017 Feb 8.

PMID:
28278682
45.

Polysonographical evaluation in a case of moderate osas treated with mandibular advancement device.

Venditti A, Basili M, Ragazzoni FM, Barlattani A Jr, Bollero P.

Oral Implantol (Rome). 2017 Jan 21;10(4):502-507. doi: 10.11138/orl/2017.10.4.502. eCollection 2017 Oct-Dec.

46.

Low-level laser therapy in the treatment of muscle-skelet pain in patients affected by temporo-mandibular disorders.

Basili M, Barlattani A Jr, Venditti A, Bollero P.

Oral Implantol (Rome). 2017 Jan 21;10(4):406-411. doi: 10.11138/orl/2017.10.4.406. eCollection 2017 Oct-Dec.

47.

Statistical analysis of the frequency distribution of signs and symptoms of patients with temporomandibular disorders.

Franco R, Basili M, Venditti A, Chiaramonte C, Ottria L, Barlattani A Jr, Bollero P.

Oral Implantol (Rome). 2016 Nov 16;9(4):190-201. doi: 10.11138/orl/2016.9.4.190. eCollection 2016 Oct-Dec.

48.

Primary and secondary metabolites of an European edible mushroom and its nutraceutical value: Suillus bellinii (Inzenga) Kuntze.

Venditti A, Frezza C, Sciubba F, Serafini M, Bianco A.

Nat Prod Res. 2017 Aug;31(16):1910-1919. doi: 10.1080/14786419.2016.1267731. Epub 2016 Dec 26.

PMID:
28013555
49.

Chemical Traits of Hemiparasitism in Odontites luteus.

Venditti A, Frezza C, Foddai S, Serafini M, Nicoletti M, Bianco A.

Chem Biodivers. 2017 Apr;14(4). doi: 10.1002/cbdv.201600416. Epub 2017 Mar 23.

PMID:
27997755
50.

All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature.

Forghieri F, Bigliardi S, Quadrelli C, Morselli M, Potenza L, Paolini A, Colaci E, Barozzi P, Zucchini P, Riva G, Vallerini D, Lagreca I, Marasca R, Narni F, Venditti A, Martelli MP, Falini B, Lo Coco F, Amadori S, Luppi M.

Clin Case Rep. 2016 Oct 24;4(12):1138-1146. eCollection 2016 Dec.

Supplemental Content

Loading ...
Support Center